Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS Database.

Nagel, Angela K; Ahmed-Sarwar, Nabila; Werner, Paul M; Cipriano, Gabriela C; Van Manen, Robbert P; Brown, Jack E

Nagel, Angela K; Ahmed-Sarwar, Nabila; Werner, Paul M; Cipriano, Gabriela C; Van Manen, Robbert P; Brown, Jack E.

Affiliation

Nagel AK; St John Fisher College, Rochester, NY, USA UR Medicine, Rochester, NY, USA anagel@sjfc.edu.
Ahmed-Sarwar N; St John Fisher College, Rochester, NY, USA UR Medicine, Rochester, NY, USA.
Werner PM; St John Fisher College, Rochester, NY, USA.
Cipriano GC; St John Fisher College, Rochester, NY, USA Anthony L. Jordan Health Center, Rochester, NY, USA.
Van Manen RP; Oracle Health Sciences Global Business Unit, Kattendijke, Zeeland Netherlands.
Brown JE; St John Fisher College, Rochester, NY, USA UR Medicine, Rochester, NY, USA.

Ann Pharmacother ; 50(1): 27-31, 2016 Jan.

Article in En | MEDLINE | ID: mdl-26497885

Subject(s)

Adverse Drug Reaction Reporting Systems; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Pancreatic Neoplasms/chemically induced; Bayes Theorem; Databases, Factual; Humans; United States; United States Food and Drug Administration; Pancreatic Neoplasms

Key words

adverse drug reaction; dipeptidyl peptidase-4 inhibitor; disproportionality analysis; oral antihyperglycemic agents; pancreatic carcinoma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adverse Drug Reaction Reporting Systems / Dipeptidyl-Peptidase IV Inhibitors Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google